Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€43.60
21.09.21
-
21.09.22
-57.56%
21.09.22

Saftman 
21.09.21 50%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.55
20.09.21
€4.00
20.09.22
-13.87%
30.09.21

Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
me8 
20.09.21 0%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
Lutz69 
20.09.21 50%
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€8.53
20.09.21
-
20.09.22
-27.86%
02.10.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
me8 
20.09.21 0%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.50
20.09.21
-
20.09.22
29.09%
21.09.21

Could be worthwhile Investment >10% per year
skyrockerZoe 
20.09.21 0%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.84
20.09.21
€4.00
20.09.22
-13.38%
02.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
me8 
20.09.21 0%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
20.09.21
€4.00
20.09.22
-22.69%
22.10.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
tbackenh 
20.09.21 60%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€34.22
20.09.21
€60.00
31.12.23
-88.71%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
20.09.21 70%
sell
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 20%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
Lokrim 
19.09.21 10%
sell
Celyad SA ADR

Start price
Target price
Perf. (%)
€3.58
19.09.21
-
19.09.22
-53.35%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
sell
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.53
19.09.21
-
19.09.22
-75.74%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
sell
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€5.30
18.09.21
-
18.09.22
-63.56%
19.09.22

Risky Investment
High risks for its business
Dependend from few customers or products
Shooter 
18.09.21 50%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€10.00
31.12.23
-79.42%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 70%
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€12.54
18.09.21
€20.00
31.12.23
-52.05%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 60%
buy
Spectrum Pharmaceuticals

Start price
Target price
Perf. (%)
€2.60
18.09.21
€5.00
31.12.23
-62.67%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 50%
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.09.21 70%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
18.09.21 50%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€2.00
18.09.22
-22.69%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
nvestor 
18.09.21 50%
sell
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€675.52
18.09.21
€209.79
18.09.22
-25.47%
02.10.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
nvestor 
18.09.21 50%
sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.00
17.09.21
-
17.09.22
73.33%
19.09.21

Risky Investment
thomasw 
17.09.21 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.94
15.09.21
-
15.09.22
0.00%
19.09.21

Risky Investment
thomasw 
15.09.21 50%
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
tbackenh 
15.09.21 60%
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.89
15.09.21
€5.85
15.09.22
1.27%
22.10.21

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Higher risks for its business
tbackenh 
15.09.21 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€41.25
15.09.21
€43.75
15.09.22
-16.61%
15.08.22

Could be worthwhile Investment >10% per year
melinda 
15.09.21 50%